In diseases such as multiple sclerosis and ischemic brain damage, IL-17/IL-17 receptor (IL-17R) interaction was shown to induce neuronal injury by bridging the gap between innate and adaptive immunity in vivo (33–35). This evidence concerns the gene IL17A and multiple sclerosis.